NCT00944632View on ClinicalTrials.gov

Dose Escalation of Different Concentrations of ZK 245186 in Atopic Dermatitis

PHASE2CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

July 15, 2009

Primary Completion Date

September 15, 2010

Study Completion Date

September 15, 2010

Conditions
Atopic Dermatitis
Interventions
DRUG

ZK 245186

Once daily topical non-occlusive application for up to 4 weeks

DRUG

Placebo (vehicle ointment)

Once daily topical non-occlusive application for up to 4 weeks

Trial Locations (3)

6045

PAREXEL International (Port Elizabeth), Newton Park

6529

PAREXEL International (George), George

9301

PAREXEL International (Bloemfontein), Bloemfontein

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY

NCT00944632 - Dose Escalation of Different Concentrations of ZK 245186 in Atopic Dermatitis | Biotech Hunter | Biotech Hunter